Myriad Genetics | MYGN - Ordinary Share Capital


Myriad Genetics reported $93.5M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agilent USD 282.22M 478K Mar/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Bio-Rad Laboratories USD 26.99M 18K Dec/2025
Bruker USD 152.22M 282K Mar/2026
Danaher USD 707.7M 800K Mar/2026
Illumina USD 151.91M 893K Mar/2026
J&J USD 2.41B 1.74M Dec/2025
Mettler Toledo International USD 20.25M 179.94K Mar/2026
Myriad Genetics USD 93.5M 400K Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Quest Diagnostics USD 111M 1000K Mar/2026
Quidel USD 67.9M 0 Dec/2025
Repligen USD 56.4M 74K Mar/2026
Revvity USD 111.8M 1.57M Mar/2026
Standard Biotools USD 386.38M 2.77M Dec/2025
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
Veracyte USD 79.79M 743K Mar/2026
Waters USD 98.17M 89K Mar/2026